Molnár, L <br/><br/>
Difference between the cerebrovascular effect of purinergic Co-ATP and that of the cholinesterase inhibitor, physostigmine, in vivo.  [electronic resource] 

 -  European journal of pharmacology  Dec 1991 
 - 81-6 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0014-2999 
<br/><br/><label>Standard No.: </label>10.1016/0014-2999(91)90014-h  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenosine Triphosphate--pharmacology<br/>Animals<br/>Blood Pressure--drug effects<br/>Cerebrovascular Circulation--drug effects<br/>Cholinesterase Inhibitors--pharmacology<br/>Cobalt--pharmacology<br/>Electroencephalography--drug effects<br/>Female<br/>Male<br/>Physostigmine--pharmacology<br/>Rabbits<br/>Stimulation, Chemical